Zobrazeno 1 - 1
of 1
pro vyhledávání: '"M. E. Ghielmini"'
Autor:
M. E. Ghielmini, S. Hsu Schmitz, G. Martinelli, F. Peccatori, U. Hess, M. Fey, E. Zucca, R. Stahel, N. Ketterer, T. Cerny
Publikováno v:
Journal of Clinical Oncology. 27:8512-8512
8512 Background: In FL, rituximab as a single agent obtains a response rate of 50–70% with an EFS of 1–3 years depending on the population studied. Some patients respond to this treatment for a prolonged time, so we investigated, in a clinical tr